# Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

> **NCT00538642** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 24 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** ziprasidone

## Key facts

- **NCT ID:** NCT00538642
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-04
- **Final completion:** 2011-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538642, "Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00538642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*